Effects of panic disorder treatments on personality disorder characteristics
โ Scribed by Stefan G. Hofmann; M. Katherine Shear; David H. Barlow; Jack M. Gorman; David Hershberger; Marcus Patterson; Scott W. Woods
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 68 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1091-4269
No coin nor oath required. For personal study only.
โฆ Synopsis
Ninety-three patients with panic disorder and mild or no agoraphobia were treated for their panic disorder by using either 11 sessions of individual cognitive-behavior therapy or imipramine. Before and after treatment, their panic disorder symptomatology was assessed, and a self-report measure was administered to measure personality disorder characteristics 8:14-20, 1998.
: Wisconsin Personality Disorders Inventory]. In addition, some patients received this personality assessment again after six monthly maintenance sessions. Both treatments were equally effective in reducing panic disorder symptomatology, and both treatments had a positive influence on personality disorder characteristics. Personality disorder characteristics did not predict treatment outcome in either group. The implications of the findings for the assessment of personality and the treatment of panic disorder are discussed. Depression and Anxiety
๐ SIMILAR VOLUMES
Parent-of-origin effect was examined in a series of 64 pedigrees with panic disorder (PD) under both the narrow and broad diagnostic models. The narrow diagnostic model defined the affected phenotype to include only the ''definite'' and ''probable'' forms of PD, whereas the broad diagnostic model in
Three drugs are currently licensed for the treatment of panic disorder: the benzodiazepine, alprazolam; the tricyclic antidepressant, clomipramine; and, most recently, the selective serotonin reuptake inhibitor, paroxetine. Alprazolam and clomipramine are eective in the treatment of panic disorder,